Safety Of Yellow Fever Vaccine And Other Live Attenuated Vaccines In Pediatric Patients With DiGeorge Syndrome

被引：0
|
作者：
de Souza, Mayara Lorena [1 ]
Dorna, Mayra de Barros [1 ]
Toscano Henriques, Gabriela Araujo [1 ]
Meireles Vieira, Pedro Henrique [1 ]
Grassi, Marcilia Sierro [1 ]
Beltran Moschione Castro, Ana Paula [1 ]
Pastorino, Antonio Carlos [1 ]
Carneiro-Sampaio, Magda [1 ]
机构：
[1] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2020年 / 40卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
812236
引用
收藏
页码：S102 / S103
页数：2
相关论文
共 50 条
  • [1] Live Vaccine Use and Safety in DiGeorge Syndrome
    Hofstetter, Annika M.
    Jakob, Kathleen
    Klein, Nicola P.
    Dekker, Cornelia L.
    Edwards, Kathryn M.
    Halsey, Neal A.
    Baxter, Roger
    Williams, S. Elizabeth
    Graham, Philip L., III
    LaRussa, Philip
    PEDIATRICS, 2014, 133 (04) : E946 - E954
  • [2] Live viral vaccines in patients with DiGeorge syndrome
    Sullivan, KE
    CLINICAL IMMUNOLOGY, 2004, 113 (01) : 3 - 3
  • [3] Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease
    Barrett, Alan D. T.
    VACCINE, 2017, 35 (44) : 5951 - 5955
  • [4] Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
    Wechsler, M. E.
    Purcell, L.
    Souza-Machado, A.
    Xu, C.
    Mao, X.
    Kapoor, U.
    Khokhar, F. A.
    O'Malley, J. T.
    Casullo, Mas, V
    Mannent, L. P.
    Ruddy, M.
    Laws, E.
    Hardin, M.
    ALLERGY, 2021, 76 : 11 - 12
  • [5] Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism
    Wang, Hong-Jiang
    Guo, Yan
    He, Meng-Jiao
    Liu, Zhong-Yu
    Ye, Qing
    Huang, Xing-Yao
    Deng, Yong-Qiang
    Li, Xiao-Feng
    Qin, Cheng-Feng
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [6] Live viral vaccines in a DiGeorge syndrome patient
    Waters, V.
    Peterson, K. S.
    LaRussa, P.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (06) : 519 - 520
  • [7] The yellow fever 17D virus as a platform for new live attenuated vaccines
    Bonaldo, Myrna C.
    Sequeira, Patricia C.
    Galler, Ricardo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1256 - 1265
  • [8] Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate
    Ikegami, Tetsuro
    EXPERT REVIEW OF VACCINES, 2017, 16 (06) : 601 - 611
  • [9] Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)
    Perez, EE
    Bokszczanin, A
    McDonald-McGinn, D
    Zackai, EH
    Sullivan, KE
    PEDIATRICS, 2003, 112 (04) : E325 - E327
  • [10] Evaluation of safety and immuno-efficacy of a next generation live-attenuated yellow fever vaccine in cynomolgus macaques
    Piras-Douce, Fabienne
    Broudic, Karine
    Chautard, Emilie
    Raynal, Franck
    Courtois, Virginie
    Gautheron, Sylviane
    Mantel, Nathalie
    VACCINE, 2023, 41 (08) : 1457 - 1470
12345